I am Keshani Hiniduma from the Department of Chemistry, University of Connecticut, USA. I am a bioanalytical chemist who is passionate about developing accessible point of care bioassays. Employing 3D printed microfluidic devices is a major component of my assay development. I am currently working on a CRISPR-based ECL assay for early Alzheimer's disease detection. Additionally, I, together with other bioanalytical chemists, have developed two COVID-19 detection assays where one detects the presence of the virus itself and the other detects the cytokine storm triggered by COVID-19. I have also developed a multiplexed assay to detect multiple cancers.
University of Massachusetts Chan Medical School
Worcester, Massachusetts, USA
Molecular, Cell and Cancer Biology
University of Connecticut
Storrs, Connecticut, USA
Chemistry
245th ECS Travel Grant
Electrochemical Society
Summer Doctoral Dissertation Fellowship
University of Connecticut
Conference Participation Award Spring 2022
University of Connecticut
Masterton (Teaching) Award
University of Connecticut